| Literature DB >> 26991908 |
Yves Martin-Prevel1, Pauline Allemand1, Laetitia Nikiema2, Kossiwavi A Ayassou1, Henri Gautier Ouedraogo2, Mourad Moursi3, Fabiana F De Moura3.
Abstract
BACKGROUND: Food-based approaches such as biofortification are meant to sustainably address micronutrient deficiencies in poor settings. Knowing more about micronutrient intakes and deficiencies is a prerequisite to designing and evaluating interventions.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26991908 PMCID: PMC4798773 DOI: 10.1371/journal.pone.0146810
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Socio-economic and demographic characteristics of the sample.
| Total | ||||
|---|---|---|---|---|
| Household | % (n = 239) | % (n = 239) | P-value | % (n = 478) |
| Household economic scale | ||||
| 51.0 | 15.5 | 0.002 | 35.9 | |
| 33.1 | 33.5 | 33.2 | ||
| 15.9 | 51.0 | 30.9 | ||
| Household food insecurity access scale | ||||
| 47.7 | 43.5 | 0.66 | 45.9 | |
| 52.3 | 56.5 | 54.1 | ||
| Women | % (n = 228) | % (n = 227) | P-value | % (n = 455) |
| Age | ||||
| 43.4 | 42.3 | 0.74 | 42.9 | |
| 56.6 | 57.7 | 57.1 | ||
| Physiological status | ||||
| 28.5 | 34.8 | 0.23 | 31.2 | |
| 10.1 | 12.8 | 11.2 | ||
| 61.4 | 52.4 | 57.6 | ||
| Body Mass Index | ||||
| 14.1 | 12.6 | 0.84 | 13.4 | |
| 81.1 | 83.4 | 82.0 | ||
| 4.8 | 4.0 | 4.5 | ||
| Children | % (n = 226) | % (n = 222) | P-value | % (n = 448) |
| Age | ||||
| 43.8 | 36.9 | 0.048 | 40.9 | |
| 56.2 | 63.1 | 59.1 | ||
| Gender | ||||
| 50.4 | 48.2 | 0.65 | 49.5 | |
| 49.6 | 51.8 | 50.5 | ||
| Weight-for-age < -2 Z-scores | ||||
| 12.2 | 15.6 | 0.48 | 13.6 | |
| 87.8 | 84.4 | 86.4 | ||
| Height-for-age < -2 Z-scores | ||||
| 28.5 | 31.1 | 0.61 | 29.6 | |
| 71.5 | 68.9 | 70.4 | ||
| Weight-for-height < -2 Z-scores | ||||
| 0.5 | 3.8 | 0.007 | 1.8 | |
| 99.5 | 96.2 | 98.2 |
1 Chi-square test
Micronutrient usual intakes and probability of adequacy among women and children by province.
| EAR | N | Mean | (Min–Max) | Median | (Q1–Q3) | PA (mean) | 95% CI | |
|---|---|---|---|---|---|---|---|---|
| Women | ||||||||
| | ||||||||
| Iron, mg | 29.1; 49.9; 23.4 | 228 | 26.1 | (6.7–67.2) | 24.6 | (20–30.8) | 0.46 | [0.44, 0.49] |
| Zinc, mg | 7; 10; 8 | 228 | 12.8 | (2.9–32.1) | 12.5 | (10.1–15) | 0.90 | [0.84, 0.96] |
| Vitamin A, μg RE | 270; 370; 450 | 228 | 212 | (2–1736) | 138 | (69–295) | 0.17 | [0.03, 0.32] |
| | ||||||||
| Iron, mg | 29.1; 49.9; 23.4 | 227 | 29.4 | (9.2–64.9) | 28.5 | (22.6–34.2) | 0.53 | [0.42, 0.63] |
| Zinc, mg | 7; 10; 8 | 227 | 11.2 | (3.4–23.4) | 10.9 | (8.9–13.1) | 0.83 | [0.76, 0.90] |
| Vitamin A, μg RE | 270; 370; 450 | 227 | 296 | (11–1560) | 237 | (169–356) | 0.27 | [0.21, 0.33] |
| Children | ||||||||
| | ||||||||
| Iron, mg | 10.8; 14.8 | 226 | 15.0 | (1.9–32.8) | 14.5 | (11.4–17.7) | 0.57 | [0.52, 0.62] |
| Zinc, mg | 2; 4 | 226 | 6.9 | (1.6–15.7) | 6.6 | (5.6–8.2) | 0.96 | [0.91, 1.00] |
| Vitamin A, μg RE | 200; 200 | 226 | 151 | (0–920) | 93 | (46–206) | 0.26 | [0.10, 0.42] |
| | ||||||||
| Iron, mg | 10.8; 14.8 | 222 | 18.1 | (5.0–50.3) | 17.3 | (13.5–21.2) | 0.67 | [0.59, 0.75] |
| Zinc, mg | 2; 4 | 222 | 6.4 | (1.9–13.0) | 6.3 | (5.2–7.5) | 0.94 | [0.87, 1.00] |
| Vitamin A, μg RE | 200; 200 | 222 | 231 | (0–1614) | 176 | (118–271) | 0.43 | [0.36, 0.51] |
1 Estimated Average Requirement (EAR) are given for non-pregnant non-lactating women; pregnant women; lactating women, respectively; and for children younger and older than 48 months-old, respectively.
2 EAR are given for a 5% iron absorption level.
3 EAR are given for a 25% zinc absorption level with the exception of lactating women for which a 35% absorption level is considered.
Biological status and percentage of deficiency among women and children by province.
| Cut-off value | N | Mean or % | (Min–Max) | Median | (Q1–Q3) | % above or under cut-off value | 95% CI | |
|---|---|---|---|---|---|---|---|---|
| Women from | ||||||||
| AGP, mg/dL | > 100 | 76 | 141.5 | (59.0–300.0) | 134.0 | (108.0–163.0) | 80.3 | [64.8, 95.7] |
| CRP, mg/L | > 5 | 76 | 5.5 | (0.0–56.6) | 2.0 | (0.8–3.9) | 21.1 | [13.8, 28.3] |
| Inflammation status (%) | ||||||||
| No inflammation | - | 76 | 17.1 | - | - | - | - | [6.4, 27.8] |
| Incubation | - | 76 | 2.6 | - | - | - | - | [0.0, 9.7] |
| Early convalescence | - | 76 | 18.4 | - | - | - | - | [6.6, 30.3] |
| Late convalescence | - | 76 | 61.8 | - | - | - | - | [48.4, 75.3] |
| Ferritin, μg/L | < 15 | 76 | 119.6 | (13.6–354.2) | 104.5 | (56.2–157.1) | 2.6 | [0.0, 7.2] |
| Ferritin corrected, μg/L | < 15 | 76 | 89.0 | (10.3–265.6) | 78.4 | (39.9–118.7) | 2.6 | [0.0, 7.2] |
| sTfR, mg/L | > 8.3 | 76 | 12.8 | (5.8–30.0) | 12.4 | (9.2–15.6) | 78.9 | [53.4, 100] |
| BIS, mg/kg | < 0 | 76 | 4.9 | (-5.1–11.0) | 5.0 | (2.5–7.4) | 3.9 | [0.0, 11.5] |
| Hemoglobin, g/dL | < 12–11 | 85 | 12.5 | (8.6–15.9) | 12.4 | (11.5–13.5) | 29.4 | [10.1, 48.7] |
| Zinc, μg/dL | < 70 | 82 | 81.0 | (52.0–115.5) | 80.0 | (68.6–91.8) | 25.6 | [0.0, 60.1] |
| Retinol, μg/dL | < 20 | 83 | 35.9 | (6.5–71.5) | 35.4 | (27.6–42.9) | 7.2 | [0.0, 15.7] |
| Retinol corrected, μg/dL | < 20 | 83 | 40.6 | (6.5–83.4) | 39.0 | (30.4–47.7) | 6.0 | [0.0, 15.4] |
| Women from | ||||||||
| AGP, mg/dL | > 100 | 75 | 118.5 | (42.0–238.0) | 114.5 | (88.8–141.5) | 68.0 | [57.8, 78.2] |
| CRP, mg/L | > 5 | 75 | 3.9 | (0.0–37.0) | 2.2 | (0.6–3.7) | 13.3 | [4.3, 22.4] |
| Inflammation status (%) | ||||||||
| No inflammation | - | 75 | 30.7 | - | - | - | - | [20.7, 40.6] |
| Incubation | - | 75 | 1.3 | - | - | - | - | [0.0, 5.1] |
| Early convalescence | - | 75 | 12.0 | - | - | - | - | [2.3, 21.7] |
| Late convalescence | - | 75 | 56.0 | - | - | - | - | [45.9, 66.1] |
| Ferritin, μg/L | < 15 | 75 | 102.0 | (6.4–339.8) | 84.1 | (42.0–147.5) | 2.7 | [0.0, 7.3] |
| Ferritin corrected, μg/L | < 15 | 75 | 79.4 | (5.8–254.9) | 71.7 | (32.9–105.5) | 5.3 | [0.0, 12.5] |
| sTfR, mg/L | > 8.3 | 75 | 12.8 | (4.1–33.0) | 12.1 | (8.3–15.1) | 76.0 | [65.1, 86.9] |
| BIS, mg/kg | < 0 | 75 | 4.4 | (-7.7–12.2) | 5.0 | (1.8–7.3) | 13.3 | [4.7, 22.0] |
| Hemoglobin, g/dL | < 12–11 | 85 | 11.9 | (3.5–18.8) | 11.9 | (10.9–13.1) | 45.9 | [30.6, 61.1] |
| Zinc, μg/dL | < 70 | 83 | 70.5 | (33.8–129.7) | 68.3 | (57.7–80.1) | 53.0 | [17.8, 88.3] |
| Retinol, μg/dL | < 20 | 84 | 26.6 | (7.7–74.4) | 24.6 | (20.6–31.6) | 20.2 | [7.0, 33.4] |
| Retinol corrected, μg/dL | < 20 | 84 | 29.1 | (8.7–74.4) | 27.0 | (22.2–34.0) | 17.9 | [5.5, 30.2] |
| Children from | ||||||||
| AGP, mg/dL | > 100 | 67 | 172.2 | (53.0–300.0) | 159.0 | (130.4–208.5) | 89.6 | [80.6, 98.5] |
| CRP, mg/L | > 5 | 67 | 15.2 | (0.3–63.4) | 4.9 | (2.8–20.8) | 50.7 | [24.7, 76.7] |
| Inflammation status (%) | ||||||||
| No inflammation | - | 67 | 10.4 | - | - | - | - | [1.5, 19.4] |
| Incubation | - | 67 | 0.0 | - | - | - | - | [0.0, 0.0] |
| Early convalescence | - | 67 | 50.7 | - | - | - | - | [24.7, 76.7] |
| Late convalescence | - | 67 | 38.8 | - | - | - | - | [17.2, 60.4] |
| Ferritin, μg/L | < 12 | 67 | 129.2 | (18.7–427.9) | 105.0 | (63–169.1) | 0.0 | [0.0, 0.0] |
| Ferritin corrected, μg/L | < 12 | 67 | 79.7 | (12.9–226.8) | 64.7 | (41.9–103.3) | 0.0 | [0.0, 0.0] |
| sTfR, mg/L | > 8.3 | 67 | 13.5 | (2.8–27.4) | 13.3 | (9.7–16.7) | 83.6 | [71.8, 95.4] |
| BIS, mg/kg | < 0 | 67 | 4.5 | (-2.5–10.2) | 4.7 | (3.0–6.4) | 6.0 | [0.0, 12.3] |
| Hemoglobin, g/dL | < 11 | 82 | 10.1 | (6.5–12.8) | 10.0 | (9–11) | 72.0 | [63.7, 80.2] |
| Zinc, μg/dL | < 70 | 83 | 61.2 | (25.4–101.4) | 60.0 | (51.3–71.2) | 73.5 | [38.7, 100] |
| Retinol, μg/dL | < 20 | 85 | 25.0 | (4.7–74.9) | 22.5 | (15.9–29.8) | 34.1 | [3.1, 65.1] |
| Retinol corrected, μg/dL | < 20 | 85 | 29.0 | (4.7–74.9) | 24.7 | (18.8–37.1) | 30.6 | [1.4, 59.7] |
| Children from | ||||||||
| AGP, mg/dL | > 100 | 70 | 174.8 | (71.0–300.0) | 170.0 | (131.0–212.0) | 90.0 | [82.0, 98.0] |
| CRP, mg/L | > 5 | 70 | 15.6 | (0–62.8) | 4.4 | (1.3–26.1) | 45.7 | [23.8, 67.7] |
| Inflammation status (%) | ||||||||
| No inflammation | - | 70 | 8.6 | - | - | - | - | [2.9, 14.2] |
| Incubation | - | 70 | 1.4 | - | - | - | - | [0.0, 5.2] |
| Early convalescence | - | 70 | 44.3 | - | - | - | - | [24.9, 63.7] |
| Late convalescence | - | 70 | 45.7 | - | - | - | - | [23.0, 68.5] |
| Ferritin, μg/L | < 12 | 70 | 134.4 | (6.2–405.4) | 119.6 | (63.7–193.2) | 1.4 | [0.0, 5.2] |
| Ferritin corrected, μg/L | < 12 | 70 | 85.7 | (6.2–214.8) | 75.5 | (42.3–122.7) | 2.9 | [0.0, 7.6] |
| sTfR, mg/L | > 8.3 | 70 | 16.2 | (6.7–26.7) | 16.3 | (12.7–19.7) | 91.4 | [79.7, 100] |
| BIS, mg/kg | < 0 | 70 | 3.8 | (-6.5–8.9) | 4.4 | (1.7–6.6) | 12.9 | [0.0, 32.2] |
| Hemoglobin, g/dL | < 11 | 83 | 9.6 | (3.6–13.2) | 9.8 | (8.5–11.0) | 72.3 | [63.8, 80.8] |
| Zinc, μg/dL | < 70 | 74 | 69.7 | (17.5–110.4) | 67.0 | (56.0–87.1) | 52.7 | [26.6, 78.8] |
| Retinol, μg/dL | < 20 | 76 | 26.0 | (5.1–85.7) | 23.4 | (17.7–29.4) | 34.2 | [25.5, 42.9] |
| Retinol corrected, μg/dL | < 20 | 76 | 30.0 | (6.7–96.3) | 27.6 | (21.1–35.2) | 18.4 | [13.0, 23.8] |
1 No inflammation: AGP < 1.0 g/L and CRP < 5.0 mg/L; incubation: AGP < 1.0 g/L and CRP ≥ 5.0 mg/L; early convalescence: AGP ≥ 1.0 g/L and CRP ≥ 5.0 mg/L; late convalescence: AGP ≥ 1.0 g/L and CRP < 5.0 mg/L.
2 Correction factors are applied according to the level of inflammation based on AGP and CRP concentrations: serum ferritin is multiplied by 0.77 during incubation, 0.53 during early convalescence and 0.75 during late convalescence.
3 Body Iron Stores = -[log(sTfR/Ferritin)-2.8229]/0.1207, using corrected value of Ferritin.
4 Correction factors are applied according to the level of inflammation based on AGP and CRP concentrations: serum retinol is divided by 0.87 during incubation, 0.76 during early convalescence and 0.89 during late convalescence.
Relationships between biomarkers and micronutrient intakes, adjusted on cofactors including inflammation markers (multivariate linear regression models).
| Ferritin μg/L | sTfR mg/L | Zinc μg/dL | Retinol μg/dL | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Coeff. | SD | P-value | Coeff. | SD | P-value | Coeff. | SD | P-value | Coeff. | SD | P-value | |
| Women | ||||||||||||
| Intake | -0.006 | 0.004 | 0.14 | -0.002 | 0.004 | 0.74 | -0.170 | 0.470 | 0.73 | 0.0003 | 0.0001 | 0.06 |
| CRP | 0.003 | 0.006 | 0.68 | -0.008 | 0.003 | 0.03 | 0.230 | 0.086 | 0.027 | -0.003 | 0.002 | 0.241 |
| AGP | 0.004 | 0.002 | 0.04 | 0.004 | 0.001 | 0.0001 | -0.022 | 0.028 | 0.458 | 0.001 | 0.001 | 0.136 |
| Age (years) | -0.016 | 0.012 | 0.23 | 0.003 | 0.004 | 0.41 | 0.114 | 0.146 | 0.46 | 0.001 | 0.006 | 0.92 |
| Physiological status | ||||||||||||
| Pregnant | 0.047 | 0.137 | 0.77 | -0.090 | 0.059 | 0.02 | 0.209 | 2.385 | 0.08 | 0.083 | 0.082 | 0.61 |
| NPNL | 0.129 | 0.179 | 0.77 | -0.199 | 0.097 | 0.02 | -10.544 | 3.990 | 0.08 | -0.033 | 0.106 | 0.61 |
| Lactating | - | - | - | - | - | - | - | - | - | - | - | |
| Body Mass Index | -0.019 | 0.021 | 0.40 | 0.007 | 0.019 | 0.70 | 0.470 | 0.595 | 0.45 | -0.011 | 0.025 | 0.66 |
| Province | ||||||||||||
| 0.093 | 0.122 | 0.47 | -0.068 | 0.060 | 0.29 | 12.217 | 5.674 | 0.06 | 0.292 | 0.091 | 0.01 | |
| - | - | - | - | - | - | - | - | - | - | - | - | |
| N | 150 | 150 | 144 | 149 | ||||||||
| R2 | 0.10 | 0.30 | 0.20 | 0.18 | ||||||||
| P-value (Model) | 0.00001 | 0.0006 | 0.00001 | 0.0001 | ||||||||
| Children | ||||||||||||
| Intake | 0.011 | 0.010 | 0.29 | 0.0001 | 0.005 | 0.93 | -0.828 | 0.775 | 0.32 | -0.0002 | 0.0001 | 0.23 |
| CRP | 0.015 | 0.002 | 0.0001 | -0.003 | 0.001 | 0.05 | -0.033 | 0.047 | 0.497 | -0.007 | 0.003 | 0.046 |
| AGP | 0.004 | 0.001 | 0.004 | 0.004 | 0.001 | 0.0001 | -0.068 | 0.026 | 0.033 | 0.001 | 0.0001 | 0.153 |
| Age (month) | 0.001 | 0.009 | 0.95 | 0.009 | 0.004 | 0.07 | 0.063 | 0.173 | 0.73 | -0.001 | 0.010 | 0.91 |
| Gender | ||||||||||||
| Male | -0.112 | 0.054 | 0.07 | -0.018 | 0.066 | 0.79 | 2.653 | 3.549 | 0.48 | -0.180 | 0.083 | 0.06 |
| Female | - | - | - | - | - | - | - | - | - | - | - | - |
| WAZ | 0.062 | 0.065 | 0.37 | -0.027 | 0.038 | 0.50 | -1.884 | 0.789 | 0.04 | 0.025 | 0.046 | 0.60 |
| Province | ||||||||||||
| 0.038 | 0.134 | 0.79 | -0.179 | 0.081 | 0.06 | -9.117 | 2.992 | 0.02 | -0.007 | 0.110 | 0.95 | |
| - | - | — | - | - | - | - | - | - | - | - | - | |
| N | 131 | 131 | 126 | 128 | ||||||||
| R2 | 0.38 | 0.40 | 0.20 | 0.13 | ||||||||
| P-value (Model) | 0.00001 | 0.00001 | 0.00001 | 0.0001 | ||||||||
1 Log-transformed variable
Wald Chi-square test
Reference category (no coefficient, no SD)
Weight-for-age (Z-score)